Aptevo Therapeutics Inc. sell stratec
Start price
09.11.20
/
50%
€28.60
Target price
09.11.21
€20.00
Performance (%)
-59.14%
End price
10.11.21
€11.69
Summary
This prediction ended on 10.11.21 with a price of €11.69. The SELL prediction by stratec for Aptevo Therapeutics Inc. performed very well with a performance of -59.14%. stratec has 50% into this predictionUnfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aptevo Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by stratec for this prediction
In the thread Aptevo Therapeutics Inc diskutieren
In the thread Trading Aptevo Therapeutics Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten